Evaluation of prostate-specific antigen as a quantifiable indicator of condom failure in clinical trials

Contraception

Volumn 60, Issue 5, 1999, Pages 289-298

  Walsh, Terri L ^a   Frezieres, Ron G ^a   Nelson, Anita L ^b   Wraxall, Brian G D ^c   Clark, Virginia A ^d  

^a Research Division   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c Serological Research Institute   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Condom failure; p30; Prostate specific antigen; Semen biologic maker; Sexually transmitted disease by infection prevention

Indexed keywords

BIOCHEMICAL MARKER; INDICATOR; PROSTATE SPECIFIC ANTIGEN;

ADULT; ANTIGEN DETECTION; ARTICLE; CLINICAL TRIAL; COITUS; CONDOM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ELECTROPHORESIS; FEMALE; HUMAN; HUMAN EXPERIMENT; INFECTION PREVENTION; MALE; NORMAL HUMAN; PUNCTURE; RANDOMIZED CONTROLLED TRIAL; SEMEN ANALYSIS; SEXUAL INTERCOURSE; SEXUALLY TRANSMITTED DISEASE; VAGINA SMEAR;

ANTIGENS; BARRIER METHODS; BIOLOGY; CLINICAL RESEARCH; CLINICAL TRIALS; CONDOM; CONDOM FAILURE; CONTRACEPTION; CONTRACEPTIVE METHODS; FAMILY PLANNING; IMMUNITY; IMMUNOLOGIC FACTORS; PHYSIOLOGY; RESEARCH METHODOLOGY; RESEARCH REPORT;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; COITUS; CONDOMS; CONTRACEPTION; CROSS-OVER STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSTATE-SPECIFIC ANTIGEN; SEMEN; SPECIMEN HANDLING; VAGINA;

EID: 0033368615     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-7824(99)00098-0     Document Type: Article

References (8)

1. Voeller B., Nelson J., Day C. Viral leakage risk differences in latex condoms. AIDS Res Hum Retrovir. 10:1994;701-710.
2. Graves H.C., Kamarei M., Stamey T.A. Identity of prostate specific antigen and the semen protein P30 purified by a rapid chromatography technique. J Urol. 144:1990;1510-1515.
3. Sensabaugh G.F. Isolation and characterization of a semen-specific protein from human seminal plasma a potential new marker for semen identification . J Forensic Sci. 23:1978;106-115.
4. Wang M.C., Valenzuela L.A., Murphy G.P., Chu T.M. A simplified purification procedure for human prostatic antigen. Oncology. 39:1982;1-5.
5. Montagnier L., Clavel F. Human immunodeficiency viruses. Webster R.G., Granoff A. Encyclopedia of Virology, Volume 2. 1994;674-675 Academic Press, Harcourt Brace & Co, London.
6. Seeger C. Hepatitis B viruses: molecular biology (human). In: Webster, RG, Granoff, A, eds. Encyclopedia of Virology, Volume 2. London: Academic Press, Harcourt Brace & Co., 1994:560-2.
7. Rawlinson L, Wraxall B. Semen quantification utilizing P30 antigen. Proceedings: Inter-American Congress of Forensic Sciences; November 2, 1982.
8. Larson M.L., Maculuso M., Bloom A., Hortin G., Hammond K.R., Blackwell R. Objective markers of condom failure. Sex Transm Dis. 25:1998;427-432.